OXB (LSE: OXB)
GBX 3.21
(2.4%)
GBX 0.08
Price as of June 20, 2025, 11:30 a.m. ET
OXB Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
OXB Company Info
OXB is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. OXB, a FTSE4Good constituent, is headquartered in Oxford, UK. It has bioprocessing and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France and near Boston, MA, US.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.